As of 2026-03-19, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (49.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -128.5%.
The range of the Relative Valuation is (47.53) - (51.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 20.3x | 19.2x |
| Forward P/E multiples | 16.8x - 19.6x | 18.4x |
| Fair Price | (47.53) - (51.18) | (49.05) |
| Upside | -127.6% - -129.7% | -128.5% |
| Date | P/E |